SCHEMBL5374501

SCHEMBL5374501

NC(=O)c1ccc2cc(C3CC(Cc4ccccc4)CCN3C(=O)c3cccnc3)[nH]c2c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SPR P35270 1/20 0.35
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTR2B P41595 1/20 0.34
MAPK14 Q16539 1/20 0.34
ACHE P22303 1/20 0.34
GRM5 P41594 1/20 0.34
OPRM1 P35372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5374499 0.75 MEN1 (0.41) CHRM2MEN1KMT2AGAASPR
SCHEMBL5374496 0.74 TACR1 (0.39) CHRM2ACHEGRM5
SCHEMBL5376322 0.72 GPR84 (0.51) MEN1KMT2AGAAGRIN2DGRIN3B
SCHEMBL1062867 0.67 CYP2C9 (0.50) CHRM2MEN1KMT2ASPRCYP2C9
SCHEMBL5376256 0.65 GAA (0.42) MEN1KMT2AGAAGRIN2DGRIN3B
SCHEMBL5369583 0.65 GAA (0.45) MEN1KMT2AGAAACHE
SCHEMBL1532785 0.64 OPRM1 (0.44) GAAOPRM1OPRD1OPRK1KCNH2
SCHEMBL5365920 0.63 MEN1 (0.47) MEN1KMT2ACYP2C9CYP2C19MAPK14
SCHEMBL5374495 0.63 GBA1 (0.42) CHRM2MEN1KMT2AL3MBTL1
SCHEMBL3490535 0.62 CYP2C9 (0.48) CHRM2MEN1KMT2ACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189739-B2 Compounds and methods to treat cardiac failure and other disorders SCIOS, INC. (US) 2007-03-13 US disclosed
EP-1080078-B1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC (US) 2006-02-01 EP disclosed
US-6589954-B1 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful SCIOS, INC. 2003-07-08 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed